First-line maintenance therapy with PARP inhibitors influences platinum sensitivity in recurrent high-grade serous ovarian carcinoma (HGSOC)

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Jiali Xu, Dongxiao Hu, Xiaodong Cheng, Fenfen Wang

DOI: 10.1016/j.ijgc.2025.103095

Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer